Related Experiment Videos
[Cutaneous blastomycosis revealing a corticoadenoma]
M El Haouri1, O Sedrati, Y Erragragui
1Service de Dermatologie, Hôpital Militaire d'Instruction Mohammed V, Rabat, Maroc.
Annales De Dermatologie Et De Venereologie
|April 25, 2001
Summary
This case study details a rare instance of blastomycosis primarily affecting the skin, leading to the discovery of a malignant corticoadrenoma. Amphotericin B successfully treated the fungal infection.
Area of Science:
- Mycology
- Dermatology
- Endocrinology
Background:
- Blastomycosis, a chronic granulomatous disease caused by *Blastomyces dermatitidis*, is uncommon.
- Cutaneous manifestations of blastomycosis are rare, particularly as the sole presenting sign.
Observation:
- A 32-year-old male presented with inflammatory facial and limb nodules.
- Histopathology confirmed blastomycosis; initial ketoconazole treatment failed.
- Skin lesions resolved with Amphotericin B, but further investigation revealed a coexisting malignant corticoadrenoma.
Findings:
- This case represents a unique association between blastomycosis and malignant corticoadrenoma.
- Blastomycosis with exclusive skin involvement is exceptionally rare, especially in Morocco.
- The co-occurrence highlights potential systemic implications and diagnostic challenges.
Implications:
- Early and accurate diagnosis of blastomycosis is crucial, even with unusual presentations.
- Amphotericin B is indicated for severe or refractory cutaneous blastomycosis.
- The association underscores the importance of thorough investigation for underlying conditions in immunocompromised or uniquely presenting patients.